Cargando…
Anti‐apoptotic protein BCL‐XL as a therapeutic vulnerability in gastric cancer
BACKGROUND: New therapeutic targets are needed to improve the outcomes for gastric cancer (GC) patients with advanced disease. Evasion of programmed cell death (apoptosis) is a hallmark of cancer cells and direct induction of apoptosis by targeting the pro‐survival BCL2 family proteins represents a...
Autores principales: | Wei, Yumin, Zhang, Liping, Wang, Chao, Li, Zefeng, Luo, Mingjie, Xie, Guomin, Yang, Xingjiu, Li, Mengyuan, Ren, Shuyue, Zhao, Dongbing, Gao, Ran, Gong, Jia‐Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272913/ https://www.ncbi.nlm.nih.gov/pubmed/37271936 http://dx.doi.org/10.1002/ame2.12330 |
Ejemplares similares
-
Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition
por: Rahman, Masum, et al.
Publicado: (2022) -
Nrz but not zBcl-xL antagonizes Bcl-wav pro-apoptotic activity in zebrafish
por: Prudent, Julien, et al.
Publicado: (2014) -
Bcl-xL promotes metastasis independent of its anti-apoptotic activity
por: Choi, Soyoung, et al.
Publicado: (2016) -
Profiling Anti-Apoptotic BCL-xL Protein Expression in Glioblastoma Tumorspheres
por: Fanfone, Deborah, et al.
Publicado: (2020) -
Levels of pro-apoptotic regulator Bad and anti-apoptotic regulator Bcl-xL determine the type of the apoptotic logic gate
por: Bogdał, Marta N, et al.
Publicado: (2013)